Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Aytu BioPharma

Youtube Subscribe

...

Ticker: AYTU

Sector: Pharmaceuticals

Aytu Biopharma, Inc. focuses on developing and commercializing novel therapeutics and consumer healthcare products. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in.
...
...
Extended Summary

Aytu BioPharma

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

Related Results

...
February 24, 2024 7:27 (London Time)

Aytu BioPharma

Aytu BioPharma reports record revenue from ADHD asset - prism marketview. Company to Report Second Quarter Fiscal 2024 Financial and Operational Res…
Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.3612
MarketCap: 16,313,059.0
High: 2.99 Low: 2.82

Open: 2.91 Close: 2.93 Change: 0.02

Read more →
...
July 05, 2023 14:44 (London Time)

Aytu BioPharma

Aytu BioPharma had revenue of $104.12M in the twelve months ending March 31, 2023, with 12.31% growth year-over-year. In the fiscal year ending June…
Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.6369
MarketCap: 8,837,532.0
High: 1.75 Low: 1.72

Open: 1.73 Close: 1.72 Change: -0.01

Read more →
...
August 21, 2023 5:41 (London Time)

Aytu BioPharma

Aytu BioPharma Announces 1-for-20 Reverse Stock Split. Chief Executive Officer Awarded $64K Worth of Stock Options. Chief Business Officer at Aytu B…
Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.7717
MarketCap: 9,334,644.0
High: 1.79 Low: 1.69

Open: 1.78 Close: 1.69 Change: -0.09

Read more →
...
April 27, 2023 23:12 (London Time)

Aytu BioPharma

Aytu Biopharmas stock price per share is $2.43 today (as of Apr 26, 2023) Aytu BioPharma stock is down -3.37% while the S&P 500 has gained 1.19%. Ay…
Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.9287
MarketCap: 8,993,354
High: 2.84 Low: 2.25

Open: 2.6 Close: 2.38 Change: -0.22

Read more →
Search
Happening Now
Categories